Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp.

Johann D.D. Pitout, Ashfaque Hossain, Nancy D. Hanson

Research output: Contribution to journalArticle

209 Scopus citations

Abstract

Organisms producing CTX-M-β-lactamases are emerging around the world as a source of resistance to oxyiminocephalosporins such as cefotaxime (CTX). However, the laboratory detection of these strains is not well defined. In this study, a molecular detection assay for the identification of CTX-M-β-lactamase genes was developed and used to investigate the prevalence of these enzymes among clinical isolates of Escherichia coli and Klebsiella species in the Calgary Health Region during 2000 to 2002. In addition, National Committee for Clinical Laboratory Standards (NCCLS) recommendations were evaluated for the ability to detect isolates with CTX-M extended-spectrum β-lactamases (ESBLs). The PCR assay consisted of four primer sets and demonstrated 100% specificity and sensitivity for detecting different groups of CTX-M-β-lactamases in control strains producing well-characterized ESBLs. Using these primer sets, 175 clinical strains producing ESBLs were examined for the presence of CTX-M enzymes; 24 (14%) were positive for blaCTX-M-1-like genes, 95 (54%) were positive for blaCTX-M-14-like genes, and the remaining 56 (32%) were negative for blaCTX-M genes. Following the NCCLS recommendations for ESBL testing, all of the control and clinical strains were detected when screened with cefpodoxime and when both cefotaxime and ceftazidime with clavulanate were used as confirmation tests.

Original languageEnglish (US)
Pages (from-to)5715-5721
Number of pages7
JournalJournal of clinical microbiology
Volume42
Issue number12
DOIs
StatePublished - Dec 1 2004

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)

Cite this